Free Trial
→ INSANE DRONE FOOTAGE (From Paradigm Press) (Ad)tc pixel
OTCMKTS:NVZMY

Novozymes A/S 5/8/2025 Earnings Results & Report

Novozymes A/S logo
$66.73 +0.42 (+0.63%)
As of 11:25 AM Eastern

Novozymes A/S was expected to report earnings on May 8, 2025. Analysts expected earnings of $0.4369 per share on revenue of $8.13 billion. Confirmed results have not been posted yet. This page will update with the reported figures, conference call transcript, and earnings documents as they become available.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Announcement Date

Novozymes A/S EPS Results

Actual EPS
N/A
Consensus EPS
$0.4369
Beat/Miss
N/A
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 8 quarters

Novozymes A/S Revenue Results

Actual Revenue
N/A
Expected Revenue
$8.13 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Novozymes A/S Earnings FAQ

Novozymes A/S' next earnings date is estimated for Thursday, November 5, 2026. MarketBeat tracks confirmed and estimated earnings dates for Novozymes A/S on the company's earnings history page.

Novozymes A/S Earnings Headlines

Novozymes A/S (OTCMKTS:NVZMY) vs. Neo Performance Materials (OTCMKTS:NOPMF) Head to Head Review
October 6, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31092139
Novozymes A/S (NVZMY) Q2 2026 Earnings Call Transcript
August 20, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4938633-novozymes-a-s-nvzmy-q2-2026-earnings-call-transcript
INSANE DRONE FOOTAGE
New drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and built in a matter of weeks. James Altucher says the site could go live as soon as October 21 and has put together a free presentation explaining what is happening inside and why the timing matters.tc pixel
October 14 at 1:00 AM  |  Paradigm Press (Ad)
Novonesis (Novozymes) B ADR NVZMY
August 5, 2026  |  morningstar.comM
Novozymes AS DRC (NVZMY)
June 24, 2026  |  investing.comhttps://www.investing.com/equities/novozymes-as-news/14
A Look At Novozymes (CPSE:NSIS B) Valuation After Recent Share Price Weakness
May 14, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/look-novozymes-cpse-nsis-b-002910692.html
See More Novozymes A/S Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Novozymes A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novozymes A/S and other key companies, straight to your email.

About Novozymes A/S

Novozymes A/S (OTCMKTS:NVZMY) was a Danish biotechnology company specializing in biological solutions based on enzymes, microorganisms and related technologies. Its products were designed to help businesses improve manufacturing efficiency, reduce resource use and develop more sustainable alternatives to conventional chemical processes.

The company supplied enzyme and microbial products for a range of industries, including household care, food and beverages, agriculture, animal health, bioenergy and industrial manufacturing. Applications included laundry and cleaning products, baking and brewing, starch processing, animal feed, crop-related solutions and the production of biofuels and other biobased materials.

Novozymes was established as an independent company in 2000 after being separated from Novo Nordisk and served customers across global markets through research, production and commercial operations in multiple regions. In January 2024, Novozymes combined with Chr. Hansen, another Danish bioscience company, to form Novonesis. Ester Baiget served as Novozymes’ president and chief executive officer before and during the combination process.

View Novozymes A/S Profile
Earnings Tools